Licheng Cai
Harbin, 150001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Knockdown of SETD2 promotes erastin-induced ferroptosis in ccRCC.
Journal: Cell death & disease
Published: December 23, 2022
RBM4 inhibits the growth of clear cell renal cell carcinoma by enhancing the stability of p53 mRNA.
Journal: Molecular carcinogenesis
Published: August 28, 2022
FBXL6 depletion restrains clear cell renal cell carcinoma progression.
Journal: Translational oncology
Published: May 07, 2022
A pyroptosis-associated signature plays a role in prognosis prediction in clear cell renal cell carcinoma.
Journal: BMC medical genomics
Published: October 19, 2021
RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
Journal: Molecular medicine reports
Published: June 29, 2020
The downregulated long noncoding RNA DHRS4-AS1 is protumoral and associated with the prognosis of clear cell renal cell carcinoma.
Journal: OncoTargets and therapy
Published: September 27, 2018
Long non-coding RNA urothelial carcinoma-associated 1 as a tumor biomarker for the diagnosis of urinary bladder cancer.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: June 23, 2017
MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: June 08, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026